Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net revenue	$ 2,970,595	$ 2,454,535	$ 1,056,389
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Grant income	$ 0	$ 10,595	$ 14,277
Costs and expenses:
Cost of net revenue	$ 2,553,169	$ 2,008,925	$ 898,601
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 162,125	$ 167,505	$ 89,346
Depreciation and amortization, excluding patient equipment depreciation	64,890	63,095	11,373
Total costs and expenses	2,780,184	2,239,525	999,320
Operating income	190,411	225,605	71,346
Interest expense, net	109,414	95,195	41,430
Change in fair value of warrant liability (note 11)	(17,158)	(53,181)	135,368
Change in fair value of contingent consideration common shares liability (note 11)	0	(29,389)	98,717
Loss on extinguishment of debt	0	20,189	5,316
Other loss (income), net	253	1,832	(3,444)
Income (loss) before income taxes	97,902	190,959	(206,041)
Income tax expense (benefit)	24,769	32,806	(11,955)
Net income (loss)	73,133	158,153	(194,086)
Income (loss) attributable to noncontrolling interests	3,817	1,978	(32,454)
Net income (loss) attributable to AdaptHealth Corp.	$ 69,316	$ 156,175	$ (161,632)
Weighted average common shares outstanding - basic (in shares)	134,175	126,306	52,488
Weighted average common shares outstanding - diluted (in shares)	138,988	133,034	52,488
Basic net income (loss) per share (note 12) (in dollars per share)	$ 0.47	$ 1.12	$ (3.08)
Diluted net income (loss) per share (note 12) (in dollars per share)	$ 0.33	$ 0.67	$ (3.08)